CEL-SCI Corp
CVM8.743USD
-0.707-7.48%
Market hours （ET）Quotes delayed by 15 min
24.58MMarket Cap
LossP/E TTM
More Details of CEL-SCI Corp Company
CEL-SCI Corporation is a late clinical-stage biotechnology company. It is engaged in research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body’s natural defense system. It is focused on the development of product candidates and technologies, including Multikine and Ligand Epitope Antigen Presentation System technology (LEAPS). Multikine (Leukocyte Interleukin, Injection), a true first-line cancer therapy, which is designed to help the immune system target the tumor at a time when the immune system is still relatively intact and thereby thought to be better able to mount an attack on the tumor. LEAPS is designed to stimulate the human immune system to more effectively fight bacterial, viral and parasitic infections as well as autoimmune conditions, allergies, transplantation rejection and cancer, when it cannot do so on its own. The LEAPS candidates include CEL-2000, CEL-4000 and DerG-PG275(Cit) (aka, CEL-5000).
Company Info
Ticker SymbolCVM
Company nameCEL-SCI Corp
IPO dateDec 08, 1983
CEOMr. Geert R. Kersten, Esq.
Number of employees- -
Security typeOrdinary Share
Fiscal year-endDec 08
AddressSuite 802
CityVIENNA
Stock exchangeNYSE American Consolidated
CountryUnited States of America
Postal code22182
Phone17035069460
Websitehttps://cel-sci.com/
Ticker SymbolCVM
IPO dateDec 08, 1983
CEOMr. Geert R. Kersten, Esq.
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Geert R. Kersten, Esq.
Mr. Geert R. Kersten, Esq.
Chief Executive Officer, Chief Financial Officer, Treasurer, Director
Chief Executive Officer, Chief Financial Officer, Treasurer, Director
72.83K
+66.91%
Ms. Patricia B. Prichep
Ms. Patricia B. Prichep
Co-Chief Financial Officer, Chief Operating Officer, Corporate Secretary
Co-Chief Financial Officer, Chief Operating Officer, Corporate Secretary
10.75K
+21.11%
Dr. Eyal Talor, Ph.D.
Dr. Eyal Talor, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
5.55K
+23.29%
Mr. Robert Eugene (Bob) Watson
Mr. Robert Eugene (Bob) Watson
Independent Chairman of the Board
Independent Chairman of the Board
3.73K
+358.60%
Mr. Bruno Jean-Marie Baillavoine
Mr. Bruno Jean-Marie Baillavoine
Independent Director
Independent Director
199.00
--
Mr. John Cipriano
Mr. John Cipriano
Senior Vice President - Regulatory Affairs
Senior Vice President - Regulatory Affairs
--
--
Mr. Mario Gobbo, Ph.D.
Mr. Mario Gobbo, Ph.D.
Independent Director
Independent Director
--
--
Dr. Daniel H. Zimmerman, Ph.D.
Dr. Daniel H. Zimmerman, Ph.D.
Senior Vice President - Research, Cellular Immunology
Senior Vice President - Research, Cellular Immunology
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Geert R. Kersten, Esq.
Mr. Geert R. Kersten, Esq.
Chief Executive Officer, Chief Financial Officer, Treasurer, Director
Chief Executive Officer, Chief Financial Officer, Treasurer, Director
72.83K
+66.91%
Ms. Patricia B. Prichep
Ms. Patricia B. Prichep
Co-Chief Financial Officer, Chief Operating Officer, Corporate Secretary
Co-Chief Financial Officer, Chief Operating Officer, Corporate Secretary
10.75K
+21.11%
Dr. Eyal Talor, Ph.D.
Dr. Eyal Talor, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
5.55K
+23.29%
Mr. Robert Eugene (Bob) Watson
Mr. Robert Eugene (Bob) Watson
Independent Chairman of the Board
Independent Chairman of the Board
3.73K
+358.60%
Mr. Bruno Jean-Marie Baillavoine
Mr. Bruno Jean-Marie Baillavoine
Independent Director
Independent Director
199.00
--
Mr. John Cipriano
Mr. John Cipriano
Senior Vice President - Regulatory Affairs
Senior Vice President - Regulatory Affairs
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
1.15%
Kersten (Geert R)
1.07%
BlackRock Institutional Trust Company, N.A.
0.38%
Geode Capital Management, L.L.C.
0.37%
MAI Capital Management, LLC
0.26%
Other
96.77%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
1.15%
Kersten (Geert R)
1.07%
BlackRock Institutional Trust Company, N.A.
0.38%
Geode Capital Management, L.L.C.
0.37%
MAI Capital Management, LLC
0.26%
Other
96.77%
Shareholder Types
Shareholders
Proportion
Investment Advisor
2.77%
Individual Investor
1.45%
Investment Advisor/Hedge Fund
0.87%
Hedge Fund
0.12%
Research Firm
0.04%
Other
94.75%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
130
326.07K
5.01%
-30.08K
2025Q1
141
362.72K
6.33%
+7.45K
2024Q4
154
8.90M
11.54%
-654.04K
2024Q3
159
7.92M
12.84%
-1.82M
2024Q2
170
8.27M
15.20%
-2.00M
2024Q1
223
9.54M
17.62%
-953.00K
2023Q4
231
8.54M
17.00%
-1.14M
2023Q3
241
7.38M
15.57%
-2.53M
2023Q2
252
7.44M
15.71%
-2.96M
2023Q1
267
7.49M
17.10%
-3.36M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
78.44K
1.53%
-584.00
-0.74%
Mar 31, 2025
Kersten (Geert R)
43.64K
0.85%
+2.29K
+5.54%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
26.09K
0.51%
-83.00
-0.32%
Mar 31, 2025
Geode Capital Management, L.L.C.
25.10K
0.49%
+6.01K
+31.51%
Mar 31, 2025
MAI Capital Management, LLC
17.55K
0.34%
+12.23K
+229.87%
Mar 31, 2025
Prichep (Patricia B)
10.75K
0.21%
+1.87K
+21.11%
Jun 30, 2025
Swisspartners Investment Network AG
10.00K
0.19%
+6.33K
+172.70%
Jun 30, 2024
Osaic Holdings, Inc.
9.64K
0.19%
-4.40K
-31.36%
Mar 31, 2025
Two Sigma Investments, LP
7.25K
0.14%
+4.53K
+166.43%
Mar 31, 2025
State Street Global Advisors (US)
7.17K
0.14%
--
--
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
Proportion0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
